revenue CAGR

We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.

Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022

19 Aug 2022 - PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligo-nucleotide-based active pharmaceutical ingredients, today announced its detailed results for the first half of […]

Read more